National Cheng Kung University

About: National Cheng Kung University is a education organization based out in Tainan City, Taiwan. It is known for research contribution in the topics: Population & Thin film. The organization has 49723 authors who have published 69799 publications receiving 1437420 citations. The organization is also known as: NCKU.

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Abstract: Summary Background Patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations have poor prognosis. We aimed to establish the efficacy of ramucirumab in patients with advanced hepatocellular carcinoma and α-fetoprotein concentrations of 400 ng/mL or higher. Methods REACH-2 was a randomised, double-blind, placebo-controlled, phase 3 trial done at 92 hospitals, clinics, and medical centres in 20 countries. Eligible patients were aged 18 years or older and had histologically or cytologically confirmed hepatocellular carcinoma, or diagnosed cirrhosis and hepatocellular carcinoma, Barcelona Clinic Liver Cancer stage B or C disease, Child-Pugh class A liver disease, Eastern Cooperative Oncology Group (ECOG) performance statuses of 0 or 1, α-fetoprotein concentrations of 400 ng/mL or greater, and had previously received first-line sorafenib. Participants were randomly assigned (2:1) via an interactive web response system with a computer-generated random sequence to 8 mg/kg intravenous ramucirumab every 2 weeks or placebo. All patients received best supportive care. The primary endpoint was overall survival. Secondary endpoints were progression-free survival, proportion of patients achieving an objective response, time to radiographic progression, safety, time to deterioration in scores on the Functional Assessment of Cancer Therapy Hepatobiliary Symptom Index 8 (FHSI-8), and time to deterioration in ECOG performance status. We also pooled individual patient data from REACH-2 with data from REACH (NCT01140347) for patients with α-fetoprotein concentrations of 400 ng/mL or greater. Efficacy analyses were by intention to treat, whereas safety analyses were done in all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT02435433. Findings Between July 26, 2015, and Aug 30, 2017, 292 patients were randomly assigned, 197 to the ramucirumab group and 95 to the placebo group. At a median follow-up of 7·6 months (IQR 4·0–12·5), median overall survival (8·5 months [95% CI 7·0–10·6] vs 7·3 months [5·4–9·1]; hazard ratio [HR] 0·710 [95% CI 0·531–0·949]; p=0·0199) and progression-free survival (2·8 months [2·8–4·1] vs 1·6 months [1·5–2·7]; 0·452 [0·339–0·603]; p Interpretation REACH-2 met its primary endpoint, showing improved overall survival for ramucirumab compared with placebo in patients with hepatocellular carcinoma and α-fetoprotein concentrations of at least 400 ng/mL who had previously received sorafenib. Ramucirumab was well tolerated, with a manageable safety profile. To our knowledge, REACH-2 is the first positive phase 3 trial done in a biomarker-selected patient population with hepatocellular carcinoma. Funding Eli Lilly.

Highly Efficient Quantum-Dot-Sensitized Solar Cell Based on Co-Sensitization of CdS/CdSe

Abstract: Cadmium sulfide (CdS) and cadmium selenide (CdSe) quantum dots (QDs) are sequentially assembled onto a nanocrystalline TiO2 film to prepare a CdS/CdSe co-sensitized photoelectrode for QD-sensitized solar cell application The results show that CdS and CdSe QDs have a complementary effect in the light harvest and the performance of a QDs co-sensitized solar cell is strongly dependent on the order of CdS and CdSe respected to the TiO2 In the cascade structure of TiO2/CdS/CdSe electrode, the re-organization of energy levels between CdS and CdSe forms a stepwise structure of band-edge levels which is advantageous to the electron injection and hole-recovery of CdS and CdSe QDs An energy conversion efficiency of 422% is achieved using a TiO2/CdS/CdSe/ZnS electrode, under the illumination of one sun (AM15,100 mW cm−2) This efficiency is relatively higher than other QD-sensitized solar cells previously reported in the literature

A 10-bit 50-MS/s SAR ADC With a Monotonic Capacitor Switching Procedure

Abstract: This paper presents a low-power 10-bit 50-MS/s successive approximation register (SAR) analog-to-digital converter (ADC) that uses a monotonic capacitor switching procedure. Compared to converters that use the conventional procedure, the average switching energy and total capacitance are reduced by about 81% and 50%, respectively. In the switching procedure, the input common-mode voltage gradually converges to ground. An improved comparator diminishes the signal-dependent offset caused by the input common-mode voltage variation. The prototype was fabricated using 0.13-?m 1P8M CMOS technology. At a 1.2-V supply and 50 MS/s, the ADC achieves an SNDR of 57.0 dB and consumes 0.826 mW, resulting in a figure of merit (FOM) of 29 fJ/conversion-step. The ADC core occupies an active area of only 195 × 265 ?m2.

Correction: Corrigendum: Assembling Composite Dermal Papilla Spheres with Adipose-derived Stem Cells to Enhance Hair Follicle Induction

Abstract: Scientific Reports 6: Article number: 26436; published online: 23 May 2016; updated: 14 November 2016 The original version of this Article contained errors in the affiliations. “Department of Cell Biology and Anatomy, National Cheng Kung University, Tainan, 701, Taiwan” was incomplete, and now reads: